Effects of Amiodarone on Cardiac Performance in Arrhythmic Dogs
World Small Animal Veterinary Association World Congress Proceedings, 2015
P. Boonpala1; P. Glangosol2; A. Kijtawornrat1; S. Sawangkoon1
1Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand; 2Small Animal Teaching Hospital, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand

At present, there are a few effective anti-arrhythmic drugs available for use in veterinary medicine. Amiodarone is a class III antiarrhythmic drug with potent antiarrhythmic and low proarrhythmic effects. However, amiodarone has possessed beta-adrenergic and calcium channel blocking activities which may have adverse effects on cardiac contractility, relaxation and thyroid function. Objectives of this study were to evaluate effects of amiodarone in terms of controlling arrhythmia, cardiac contractility and relaxation, and thyroid toxicity. Eight dogs with organic heart diseases were recruited and confirmed arrhythmia types by Lead II and 24-h ambulatory ECGs. Echocardiograms were performed before and after treated with amiodarone at a 10 mg/kg loading dose twice a day for 7 days, followed by a 5 mg/kg maintenance dose, once a day. After treated with amiodarone for 15 days, the result showed that the total arrhythmic count was significantly decreased (p < 0.05). Pre-ejection period and isovolumic contraction time were significant prolongations (p < 0.05). Tei index tended to increase (p = 0.07). After 60 days, plasma tri-iodothyronine (T3) and tetra-iodo-thyronine (T4) were not significant alterations (p = 0.44 and 0.37, respectively).

In conclusion, amiodarone is a potent antiarrhythmic drug which has minor negative effects on inotropy and lusitropy. Thyroid toxicity of amiodarone is still controversial, but does not have impact on clinical signs. Therefore, the dose of amiodarone recommended in this study is safe for treated arrhythmic dogs with organic heart diseases.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

P. Boonpala
Department of Physiology
Faculty of Veterinary Science
Chulalongkorn University
Bangkok, Thailand


MAIN : Cardiorespiratory Medicine & Surgery : Amiodarone & Cardiac Performance
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27